Avio Smart Market Stack has acquired a minority stake in Huwel Lifesciences to jointly launch patented molecular diagnostic products in India. Their flagship Quantiplus® MTB FAST platform reduces TB testing costs by nearly 60%, positioning the alliance to disrupt India’s ₹1,000 crore diagnostics market and strengthen public health infrastructure.
Avio Smart Market Stack Limited (ASMS), formerly Bartronics India, has formalized a strategic alliance with Huwel Lifesciences to revolutionize India’s molecular diagnostics landscape. The partnership is designed to break monopolies in TB testing, expand affordable healthcare solutions, and leverage patented innovations for large-scale institutional contracts.
Key Highlights
-
Strategic Investment: ASMS acquires a minority stake in Huwel Lifesciences, ensuring long-term collaboration in diagnostics-linked opportunities.
-
Revenue-Sharing Model: ASMS will receive a defined share of net project revenues from healthcare contracts secured through this partnership.
-
Affordable Testing: Huwel’s Quantiplus® MTB FAST platform delivers TB testing at ₹340 per sample, compared to ₹700–₹1,000 in existing systems.
-
Market Potential: The alliance targets India’s ₹1,000 crore TB diagnostics market, with scalability across public health programs.
-
Infrastructure Compatibility: The platform integrates seamlessly with existing RT-PCR systems, reducing adoption barriers for hospitals and labs.
-
Public Health Impact: Lower costs and faster diagnostics are expected to strengthen India’s fight against tuberculosis, a major national health challenge.
Sources: The Hindu BusinessLine, Telangana Today, ScanX News, Indian Startup Times